Home › Sjögren's Disease › Pennsylvania
Sjögren's Disease clinical trials in Pennsylvania
4 studies for Sjögren's Disease are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UPMC Hillman Cancer Center, Pittsburgh
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT03816345The Myelin Disorders Biorepository Project
- The Children's Hospital of Philadelphia, Philadelphia
- University of Pennsylvania, Philadelphia
- University of Pittsburgh Medical Center, Pittsburgh
RecruitingObservational study
All ages · All sexes · Updated Nov 12, 2026 · NCT03047369A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
- Altoona Center for Clin Res, Duncansville
- Rheumatology Specialty Center - Willow Grove Office, Willow Grove
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Nov 9, 2026 · NCT07737743Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
- Altoona Center for Clinical Research, P.C., Duncansville
- Clinical Research of Philadelphia, LLC, Philadelphia
- Rheumatic Disease Associates, Ltd., Willow Grove
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Oct 19, 2026 · NCT07404865From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.